Skip to main content

Table 4 Serum transfer and challenge with SHIV sbg

From: Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model

GROUP

ID NO.

VACCINE

SEROLOGICAL RESPONSES

   

Binding antibodies(log10 reciprocal titre)DOCa

Virus neutralisation activity (50% virus inhibition log 10 titre) DOCa

   

W61D rgp120

IIIB rgp120

SHIVW61D

SHIVsbg

E

C37

Serum from group A

3.9

3.9

2.4

<1

 

C38

 

3.9

3.9

2.4

<1

 

C39

 

4.3

3.6

2.5

<1

 

C40

 

4.1

3.6

2.5

<1

  1. DOC = day of challenge.
  2. a = time of sampling.
Back to article page

Retrovirology

ISSN: 1742-4690

Contact us